SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEMASURE (HMSR) - Buyout in the works?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LAWREAL who wrote (4)4/3/1997 6:43:00 PM
From: hcm1943   of 88
 
no shit, these turkeys caused this stock to drop about
15 pts in the last year with thier ill concieved
purchase of a plasma business from Novo Nordisk and
defended the purchase up until the time the realized it
was going to be a hugh drain on resources and earnings.
I've had ongoing conversations with Davis and kind of
hate to see him go because I don't think he was the CFO
when the other idiots got bagged. At least we still have
an ongoing lawsuit against Upjohn which we may win. But
considering it was the outgoing mgmt that proffesed a
succesful outcome to the litigation I now have to
believe the jury is out on how metorious HMSRs case is
vs Upjohn. I hope to speak to the new team tomorrow and
will relay what I find out. Keep in mind HMSR has about
$2 in cash and a $50,000,000 three ;year agreement with
the ARCBB over 3 yrs with more to follow when ARC
contract runs out with Paul Corp in Sept. IMHO the worst
is over.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News